- GlobeNewswire•2 days ago
HAMPTON, N.J., Sept. 23, 2016-- Celldex Therapeutics, Inc. announced today that Anthony Marucci, Co-founder, President and Chief Executive Officer, and Thomas Davis, M.D., Executive Vice President and ...
- Investopedia•5 days ago
While the company has a large pipeline of drugs under development, its short-term sustainability is questionable amid a significant fall in stock prices.
- 24/7 Wall St.•12 days ago
24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in late-September and October.
Celldex Therapeutics, Inc. (CLDX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||3.70 x 800|
|Ask||3.90 x 5500|
|Day's Range||3.69 - 3.87|
|52wk Range||2.96 - 18.62|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-2.88|
|Avg Vol (3m)||2,008,952|
|Dividend & Yield||N/A (N/A)|